Phio Pharmaceuticals Corp. (PHIO) Reports Q2 Loss of $1.47
Tweet
Share
E-mailGet Alerts PHIO Hot Sheet
Join SI Premium – FREE
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported Q2 EPS of ($1.47).
For earnings history and earnings-related data on Phio Pharmaceuticals Corp. (PHIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- Morgan Stanley continues to recommend exposure to the broadening theme
- Equinor ASA (ADR) (EQNR) PT Lowered to $37 at TD Cowen
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
